Latest Financial Position News

Great Divide Mining Ltd has taken a decisive step from explorer to gold producer by securing a farm-in agreement for the Adelong Gold Project and raising $2.05 million to fund production restart and exploration activities.

Artemis Resources has reported significant high-grade gold intersections from its initial diamond drilling phase near the Carlow deposit, while also consolidating lithium rights in a new joint venture with GreenTech Metals, positioning itself strongly in Western Australia’s mineral landscape.

Lark Distilling Co. reported a robust Q3FY25 with net sales rising 31% to $4.3 million, driven by growth in travel retail, ecommerce, and exclusive whisky releases. The company also progressed its Pontville distillery redevelopment and maintained positive operating cash flow.

Top End Energy has completed its strategic acquisition of Serpentine Energy, significantly expanding its natural hydrogen footprint in Kansas and advancing towards its first well drilling, while also progressing exploration in Australia’s Northern Territory.

Island Pharmaceuticals has completed dosing in the Phase 2b cohort of its dengue fever trial, with pharmacokinetic targets met and top-line results expected next month. The company also strengthened its balance sheet by raising $1.94 million through option exercises.

PeopleIn Limited reported a $6.3 million Q3 FY25 EBITDA, down from $6.9 million last year, affected by severe weather in Queensland. Strong cash flow helped reduce debt, underscoring resilience despite ongoing trading challenges.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet the company progresses its climate ambitions with the successful Moomba CCS project and robust decarbonisation efforts.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% revenue decline, offset by progress in carbon capture and storage projects and emissions reductions. The company maintains a strong balance sheet while setting ambitious climate targets.

Southern Palladium’s March quarter report highlights strong project economics from its Bengwenyama PGM project, with a $1.06 billion NPV and a mining right decision expected in Q2 2025. The company is progressing a Definitive Feasibility Study and project optimisation to accelerate production.

Amplia Therapeutics has completed recruitment early for its Phase 2a ACCENT trial in advanced pancreatic cancer, reporting encouraging interim results and advancing a second trial with FDA-backed protocol changes.

Pancontinental Energy reports a significant 3.8 billion barrels of net prospective oil resources at its Saturn Complex in Namibia’s PEL 87, advancing farmout talks and environmental approvals for exploration drilling.

Middle Island Resources completed analysis of its maiden drilling at the Georgina Project and secured three new exploration permits in Queensland, while renewing its board with two new directors post-quarter.